Sai Life Sciences Ltd.

NSE: SAILIFE · Healthcare

₹1,582.80

as of 28 Sep 2026

AI verdict · 28 Sep 2026

Bearish 68% confidence

Volume collapse to 29% of average on a 34% rally above the 200-day trend, combined with proximity to 52-week highs and single-quarter…

Strongest bull point

Q1 FY27 net profit grew 21% sequentially to Rs 73.29 crore, and the CRISPR/Cas9 partnership with ERS Genomics strengthens R&D capabilities in precision medicine, supporting the 77% outperformance versus a declining NIFTY.

Strongest bear point

Latest volume of 267k shares (29% of 20-day average) on an extended rally 34% above the 200-day EMA is a classic narrow-based setup; stock sits only 5% below 52-week highs with limited upside room and high profit-taking risk.

Technical Forecast · next 10 trading days

Expected

₹1,173.39 -25.9%

Range

₹1,166.87 – ₹1,180.02

Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on SAILIFE, misses included

Bearish 28 Sep 2026 → now Scores 28 Oct 2026

₹1,582.80 → ₹1,582.80 0.0%

Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →

More Healthcare